• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312

Pyridine, 2-(4-fluorophenoxy)- (CAS No. 1173294-78-4): A Comprehensive Overview in Modern Chemical Research

Pyridine, 2-(4-fluorophenoxy)-, identified by the Chemical Abstracts Service Number (CAS No.) 1173294-78-4, is a fluorinated aromatic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its pyridine core substituted with a 4-fluorophenoxy group, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The structural motif of Pyridine, 2-(4-fluorophenoxy)- combines the electron-deficient pyridine ring with the electron-donating effect of the fluorophenyl group. This dual functionality not only enhances its solubility in polar organic solvents but also imparts specific electronic and steric properties that are highly beneficial in medicinal chemistry. The presence of the fluorine atom at the para position of the phenyl ring further modulates its reactivity and binding affinity, making it an attractive scaffold for drug design.

In recent years, Pyridine, 2-(4-fluorophenoxy)- has been extensively studied for its potential applications in the development of novel therapeutic agents. Its structural features have been leveraged to design molecules with enhanced pharmacological profiles. For instance, derivatives of this compound have shown promise as kinase inhibitors, particularly in targeting pathways involved in cancer and inflammation. The fluorine atom's ability to influence metabolic stability and binding interactions has been exploited to improve drug efficacy and reduce off-target effects.

One of the most compelling aspects of Pyridine, 2-(4-fluorophenoxy)- is its role as a key intermediate in the synthesis of small-molecule drugs. Researchers have utilized this compound to develop inhibitors of enzymes such as Janus kinases (JAKs) and tyrosine kinases (Tyrosine Kinase Inhibitors, TKIs). These inhibitors are critical in treating a variety of inflammatory and autoimmune disorders. The fluorophenoxy group provides a hinge-binding motif that interacts with critical residues in the target enzymes, leading to potent inhibition.

The synthesis of Pyridine, 2-(4-fluorophenoxy)- involves multi-step organic reactions that highlight the compound's synthetic versatility. Common synthetic routes include nucleophilic aromatic substitution reactions where a halogenated derivative of pyridine reacts with 4-fluorophenol under basic conditions. These reactions often employ palladium-catalyzed cross-coupling techniques to achieve high regioselectivity and yield. The use of advanced catalytic systems has enabled researchers to optimize these processes, making large-scale production more feasible.

The pharmacokinetic properties of compounds derived from Pyridine, 2-(4-fluorophenoxy)- have been thoroughly investigated. Studies have demonstrated that the fluorine atom enhances metabolic stability by resisting hydrolysis and oxidation. This stability is crucial for maintaining drug activity over time and ensuring consistent therapeutic effects. Additionally, the fluorinated aromatic ring contributes to blood-brain barrier penetration, which is essential for treating neurological disorders.

In academic research, Pyridine, 2-(4-fluorophenoxy)- has been employed as a building block for exploring novel drug candidates. Its scaffold has been modified to develop molecules with improved pharmacological properties such as increased selectivity and reduced toxicity. Computational modeling techniques have been used to predict how structural modifications will affect biological activity. These models have helped researchers design derivatives with optimized binding affinities and favorableADME (Absorption, Distribution, Metabolism, and Excretion) profiles.

The industrial application of Pyridine, 2-(4-fluorophenoxy)- extends beyond pharmaceuticals into agrochemicals and specialty chemicals. Its derivatives have been incorporated into herbicides and pesticides due to their ability to interact selectively with biological targets. The fluorinated aromatic moiety enhances the environmental stability of these compounds while maintaining their efficacy against pests and weeds.

The future prospects for Pyridine, 2-(4-fluorophenoxy)- are promising as research continues to uncover new applications and synthetic strategies. Advances in green chemistry principles are driving efforts to develop more sustainable methods for producing this compound without compromising yield or purity. Additionally, collaborations between academia and industry are fostering innovation in drug discovery programs that utilize this versatile scaffold.

In conclusion, , CAS No. 1173294-78-4>, represents a significant advancement in chemical research with its broad utility in pharmaceutical development and industrial applications. Its unique structural features have enabled the creation of novel therapeutic agents with improved pharmacological profiles. As research progresses, this compound is expected to play an increasingly important role in addressing unmet medical needs across various therapeutic areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)